BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 29, 2016
View Archived Issues
Zinc-13407541 partially reverses hypophosphatemic effects of excess FGF-23 in vivo
Read More
Janssen initiates phase IIb study of simeprevir, odalasvir and AL-335 for HCV
Read More
IL-31 levels are upregulated in dermatomyositis
Read More
PRMT5 inhibitors could represent new therapeutic approach in treatment of psoriatic diseases
Read More
Hetero Research Foundation patents antiviral agents
Read More
Blueprint Medicines reports data from ongoing phase I trial of BLU-554 in HCC
Read More
FDA gives fast track designation to Epizyme's tazemetostat
Read More
Sichuan Haisco Pharmaceutical discloses M3 receptor antagonist and/or beta2-adrenoreceptor agonists
Read More
Bristol-Myers Squibb describes bromodomain inhibitors
Read More
FDA accepts sBLA for Keytruda in patients with MSI-H cancer
Read More
Kancera develops HDAC inhibitors
Read More
European Commission approves Glyxambi for type 2 diabetes
Read More
Phase II trial of cavosonstat in cystic fibrosis does not meet primary endpoint
Read More
EMA grants full aproval to vismodegib
Read More
Oxford BioMedica establishes strategic alliance with Orchard Therapeutics
Read More
Mutations in FAM105B gene may be involved in autoinflammatory diseases
Read More
GTx's enobosarm achieves primary efficacy endpoint in phase II trial
Read More
Inisync available in Japan
Read More
Idera and Vivelix sign license and collaboration agreement for IMO-9200
Read More
MonoSol files NDA with FDA for Tadalafil PharmFilm in the treatment of erectile dysfunction
Read More
Cyfip2 is a genome-wide significant genetic factor for binge eating
Read More
Galapagos initiates phase I study of GLPG-2737 in cystic fibrosis
Read More
Relypsa's patiromer gains FDA approval of sNDA, black box warning removed from label
Read More
Recro Pharma discloses positive results from phase III trial of i.v. meloxicam
Read More
VB-037 shows promise in EAE model
Read More